Rahul Singhvi

Rahul Singhvi is a global leader in the Life Sciences industry and is cofounder and CEO of the biomanufacturing company National Resilience, Inc. Prior to co-founding Resilience in 2020, Rahul was an Operating Partner at Flagship Pioneering, where he was responsible for founding and operating companies launched from Flagship’s innovation foundry, Flagship Labs. Before joining Flagship, Rahul served as the Chief Operating Officer of the vaccine business unit at where he was responsible for worldwide vaccine CMC and manufacturing operations. Before Takeda, Rahul was President and CEO of Novavax, Inc. and held several positions with Merck & Co in R&D and manufacturing.

Rahul graduated as the top ranked chemical engineer from Indian Institute of Technology (IIT), Kanpur and earned both his masters and doctoral degrees in Chemical Engineering from MIT. He earned his MBA from the Wharton School at the University of Pennsylvania where he graduated as a Palmer Scholar.

Rahul serves on the Board of Trustees of the Keck Graduate Institute, and on the Board of Directors for Codexis (Nasdaq: CDXS), and Garuda Therapeutics (private).